chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild fever for a few days after the vaccination as well as muscle aches and fatigue. On the day reported, started getting tingling on right face below nose similar to cold sore have had in the past. Then got much worse and herpatic lesions spread to end of nose and up nose and on face. Had an appointment and got put a week of Valtrex.
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021 at 1:15 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Mar-2021 at 1:15 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) outcome was unknown. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Age of patient was reported as 69.89 for dose administered on 03-Mar-2021. Concomitant product use was not provided by the reporter. Batch number 014M20A underwent temperature excursion on 03-Mar-2021 with temperature 35 degrees Fahrenheit from 01:00 PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 03-Mar-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour. No treatment medications were reported. This case was linked to MOD-2022-566976 (Patient Link).
lack of response - information has veen received from a health care profesional concerning an adult female patient who in approximately 1999 was vaccinated with the varicella viurs vaccine live series .  Subsequently the patient had a negative titer.  Unspecified medical attent was sought.
Day 1: hearing loss in left ear, face felt sunburned, pain at surgical site (had oral surgery 4/15/21), fatigue, headache Day 2: fatigue, headache Day 3: fatigue, headache Days 4-6: headache
Patient received an expired 1st dose of vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired 1st dose of vaccine) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired 1st dose of vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired 1st dose of vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.  A nurse opened the vial at 10:30 AM 19-Aug-2021 and kept at refrigerated temperature.
Might miss the 2nd Dose of vaccine; Soreness of Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of Arm) and PRODUCT DOSE OMISSION ISSUE (Might miss the 2nd Dose of vaccine) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness of Arm). On 27-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Might miss the 2nd Dose of vaccine). At the time of the report, PAIN IN EXTREMITY (Soreness of Arm) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Might miss the 2nd Dose of vaccine) had resolved. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported.  Treatment information was not provided. Additional information was provided that patient had received steroids. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
He is tested positive for Covid; He is tested positive for Covid.; This is a spontaneous report received from Pfizer sponsored Program. A contactable male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 07Apr2021 as Single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient went to the clinic because he had bad allergies and get tested, found that he tested positive for COVID-19. The outcome for events were unknown,  No follow-up attempts are needed. No further information is expected.
p/vax pt  c/o pain lt triceps region; swelling; & myasthenia/warmth; also feels weak;lt grip; area of erythema;
Had flu shot on 11-14-03 and next morning while getting out of bed felt real dizzy. Went away but periodically felt thru the day and next few days lightly.
Developed fever which peaked at 103 (ear thermometer) and swelling over the site of the injection (L deltoid). Mom estimates the redness and swelling peaked at about 72 hours after vaccination and reached about 5x15 cm.
Information has been received from a Registered Pharmacist concerning a 67 year old male with no pertinent medical history or drug allergies/reactions, who on 22-JAN-2011 was vaccinated subcutaneously with "a single vial" dose of ZOSTAVAX (Merck) (Lot #669191/14656Z, exp 01/28/2012). There was no concomitant medication. Pharmacist reported that the patient experienced adverse reactions after receiving a dose of ZOSTAVAX (Merck). The patient experienced swelling, about "size of a silver dollar" and itching around injection site (approximately on 22-JAN-2011). No lab diagnostic studies were performed. The patient was treated with ALLEGRA for the adverse events. The patient's outcome was unspecified at the time of the report. Follow up information has been received from a Registered Pharmacist concerning a 67 year old retired male patient with no pertinent medical history, no drug allergies or reactions and no illness at the time of vaccination, who on 22-JAN-2011, was vaccinated subcutaneously in the left arm with the first dose of ZOSTAVAX (Merck) (Lot #669191/14656Z, exp 01/28/2012). The pharmacist reported that on 23-JAN-2011, the patient had itching around injection site and swelling about "size of a silver dollar", which lasted "1 week". Patient recovered from adverse events on 30-JAN-2011. It was reported that patient did not seek medical attention. No further information is available.
flu vaccine made me sick; Initial information received on 24-Sep-2023 regarding an unsolicited valid social media non-serious case received from a Patient.  This case involves a patient of unknown demographics whom flu vaccine made me sick after receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza Vaccine produced by unknown manufacturer formulation, strength, dose, expiry date, lot number not reported via unknown route in unknown administration site for prophylactic vaccination (immunization).Information on the batch number was requested.  On an unknown date the patient developed flu vaccine made me sick (illness) (unknown latency) following the administration of Influenza Vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event flu vaccine made me sick.  At time of reporting, the outcome was Unknown for the event flu vaccine made me sick.
vaccination failure; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Mar2021 as dose 1, single (Lot number: ER2613), in left arm, on 13Apr2021 as dose 2, single (Lot number: EW0158), in left arm and on 24Oct2021 as dose 3 (booster), single (Lot number: FH8020) at the age of 47 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Allergies- seasonal" (unspecified if ongoing); "Lactose intolerant" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant) with onset 02Jul2022, outcome "not recovered"; VACCINATION FAILURE (medically significant) with onset 02Jul2022, outcome "not recovered". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results; (10Jul2022) Negative; (12Jul2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient took Paxlovid from 02Jul2022 to 08Jul2022 for covid-19. Patient received Mucinex, afrin spray, sore throat, spray from 03Jul2022 to 05Jul2022. Covid rebound (symptoms came back and tested positive on antigen test), after completing 5 day Paxlovid treatment and receiving negative antigen test two days before testing positive.  Follow-up attempts are completed. No further information is expected.
Pt was treated at County Health Department on 10-15-19 for contact to an STD. She was given Metronidazole (4 tablets) and Hepatitis A vaccine around 9:50am. Pt was released for checkout by RN at 10:00. At around 10:15, a nurse was paged to the front lobby where pt was found to be in distress. EMS was called by clerk. She was complaining of shortness of breath and heart racing. Pt was moved to a exam room and transferred to bed. 1st set of vitals (10:18) : BP-110/70; HR-94, SpO2-98%  RA; Resp: 22 bpm. EMS arrived at 10:20 and 2nd set of vitals: BP-103/57; HR-98; SpO2-95% RA; Resp: 22bpm. 3rd set of vitals taken at 10:34am: BP-98/60; HR-98; SpO2:97% RA; Resp:18 bpm. Pt was calming down, and breathing normal. Informed pt that it would be best if she would consider going to the ER for evaluation for her safety. After thinking about it, pt decided to go. Pt walked to stretcher and was transported by EMS EMTs out of clinic at 10:40am to  ER of patient's choice.
Extreme brain fog/cognitive dysfunction to the point I couldn?t drive a car due to delayed reaction time. Struggled to function at my job due to brain fog/forgetfulness/mental processing issues. Major balance issues, walked crooked and couldn?t stand on my toes or walk in straight line toe to toe. Fatigue. Heart palpitations and lightheadedness. Enlarged painful and palpable lymph node under armpit on side of vaccination.
pt recv vax 9DEC96 & c/o sore deltoid that PM;10DEC96 lt deltoid hard;12DEC96 c/o muscle spasm lt side of back intermittent spasms;13DEC966 cont spasms w/pain producing tears;tx w/heating pad & Ibuprofen;diff exhaling;
Since 11/3/08- W/E of Nov 8 & 9. -> sender couldn't hardly life her arm - was weak.  On & off ever since.  12/1/08 left arm- had to hold arm close to her body & use right arm to lift left arm.  I had taken ADVIL 200 mg X 6 tabs at one time on evening 11-30-08 for # 8 pain; went down to 2 or 4.  Since then gets bad & goes away for a couple of days.  (Education given on proper dose of ADVIL.)
Patient reports numbness and tingling in both feet, temporary nausea, Sore throat and loss of voice (hoarseness)
From telephone contact received at AP on 04/26/2002, it was reported that patient received first post exposure series of Imogram HT and Imovax on 04/08/2002.  Patient reported that he felt tired and achy after first dose.  After second dose of Imovax on 04/11/2002, he had chills and general malaise.  Patient also experienced chills and sweating after the third dose of Imovax on 04/15/2002.  Patient also reported that he is now flushed and very tired after the fourth dose of Imovax on 04/22/2002.
Please note unknown what series of COVID vaccine this is for the patient.   An intern used the incorrect size needle to administer the Covid vaccine. The needle size used was a 5/8 inch needle, when the correct size that should have been used was a 1 inch needle. The correct dose was given to all patients. Based on CDC recommendations, there is no need to revaccinate any patient that was administered the dose in the wrong location; in this case the vaccine was given SubQ rather than intramuscular, based on the length of the needle. All patients were notified of this error and were given advise on what to expect. All patients were informed that no harm was done, the vaccine was still effective, and no additional dose is required based on CDC guidelines. As a result of these errors, reeducation was given to the pharmacy student, and the area within the pharmacy that contains all vaccination related supplied were relabeled to make it more clear for everyone administering vaccines.
ADMINISTRATION BY UNLICENSED ROUTE (MEDICATION ERROR, MEDICATION ERROR) (MED ERROR) - Not Reported SWELLING AT THE SITE OF INJECTION (INJECTION SITE EDEMA, INJECTION SITE EDEMA) (EDEMA INJECTSITE) - recovered/resolved discoloration at the injection site (injection site reaction, injection site reaction ) (inject site react ) - recovered/ resolved INDURATION AT THE SITE OF INJECTION (INJECTION ISTE REACTION, INJECTION SITE REACTION ) (INJECT SITE REACT ) - recovered/ resolved  A report was received from a health care professional on 24 October 2003 concerning a 48 year old female vaccine who experienced swelling a discoloration at the site of injection an unspecified length of time after inadvertently receiving Fluvirin by subcutaneous injection on 24 October 2003.  On 24 October 203 the vaccine received Fluvirin by subcutaneous injection.  An unspecified length of time after receiving fluvirin the vaccine experienced swelling and discoloration at the injection site.  The outcome of the event was not reported. There was insufficient information to determine the reporter's causality assessment.  Update 1, 12 January 2004.  A follow up letter was received from  a health care professional indication that the swelling and in duration at the site of injection began on 24 October 2003 and had completely subsided after 3 days.  No residual effects were noted accourding to the reporter.  No follow up pending, all information received.
Patient request injection be given in gluteus due to not much muscle in arm and previous in arm hurt badly. No reaction happened. This injection was given before being advised the the gluteus was not preferable site.
Following lasted over 3 weeks: fever, night sweats, nausea, diarrhea, weakness, fatigue, malaise.
Patient  with recent swing stay here 9/29- 11/26. Returned after only being home for few hours. Having  severe panic attack, apt inhabitable, infested with bedbug, robbed and ransacked. ER found patient to have AKI. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Pt vaccinated with MMR developed rash & itching under both axillas & onto scapulae.
Pt had his vaccines around 10:30 and 2 hours later, he had a seizure and fell against the dishwasher. It lasted less than a minute. The ER doctor said that's what I got for waiting so long for his 2 year old shots.
Severe Migraine. May June, June and July- Migraine will come and got but would last 3days each time. I had surgery in August and the migraines came back. Burning of my skin (sheen, skin, scalp) and neuropathy. Tingling and numbness on my face, feet and back -I am still experiencing the tingling and numbness on my face everyday since the vaccination.
I received the Pfizer booster shot on  Friday, 12/10/2021; Awaken Saturday 12/11/2021 and could not walk on left leg, severe pain back of knee and swollen; the left arm very sore which i expected to be from the vaccination up to 2 day.  On Sunday 12/12/2021 I was in severe pain from left leg and worried about possible DVT.  I went to Emergency Room who referred me to see an Orthopedic Specialist if my pain was not gone within a week.
Patient came down with the Mumps after receiving the Mumps vaccine.  I will not allow my kids to get the MMR as I believe there is a strong link to autism.  After daycare called we took him to the ER.  He was seen by several doctors and we were sent home to await results.  When we got home the county health department called and told us that we were under quarantine for 10 days.  When the test results finally came back they were positive for Mumps.  As some results of contracting the Mumps are not known until adulthood (such as sterility) we will have to wait to see if my son will be able to have children.  I consider the fact that since we will not know if he was permanently harmed by the Mumps I will consider him to be permanently disabled until it's proven otherwise.  03/17/2008 MR received from PCP including vax record, ER record and labs. Child received Mumpsvax on 4/27/2006 per parenta request for single vaccine.  Seen in ER 5/18/2006 for facial swelling with DX: L Parotiditis.
p/vax inj site became red & extremely tender, warm to touch, redness extended to lt elbow x lt torso;tx w/Ibuprofen w/effect;
nothing solid, they runs; "funny belch that felt like food poisoning"; sweaty; an hour later started throwing up; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (nothing solid, they runs), FOOD POISONING ("funny belch that felt like food poisoning"), HYPERHIDROSIS (sweaty), VOMITING (an hour later started throwing up) and PYREXIA (fever) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2021, the patient experienced DIARRHOEA (nothing solid, they runs), FOOD POISONING ("funny belch that felt like food poisoning"), HYPERHIDROSIS (sweaty), VOMITING (an hour later started throwing up), PYREXIA (fever) and CHILLS (chills). At the time of the report, DIARRHOEA (nothing solid, they runs), FOOD POISONING ("funny belch that felt like food poisoning"), HYPERHIDROSIS (sweaty), VOMITING (an hour later started throwing up), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided. Patient provided that he is not currently taking any medication, but is borderline of being diabetic(prior to vaccine). Consumer stated he received his first Moderna COVID-19 Vaccine on 20May2021 (Lot: Unknown, Exp: Unknown, left upper arm). Starting yesterday, 24May2021, the consumer stated "nothing solid, they runs" (referring to bowel movements). He also started to experience a "funny belch that felt like food poisoning". He then stated, "an hour later started throwing up". Also reported fever, chills, and felt sweaty. Consumer stated the "runs" and "belching" have not resolved, but everything else has. Consumer provided he is not currently taking any medication, but is borderline of being diabetic (prior to vaccine). Consumer also stated prior to vaccine (about two weeks ago) he was throwing up and having the runs.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: non-significant follow up
Really weak; Really dizzy; Feel like with the flu, but no muscle aches; Not well; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Really weak), DIZZINESS (Really dizzy), INFLUENZA LIKE ILLNESS (Feel like with the flu, but no muscle aches), MALAISE (Not well) and PYREXIA (Fever) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0297AvA) for COVID-19 immunisation.     The patient's past medical history included Atrial fibrillation and Cancer (NOS) (twice). Concurrent medical conditions included Drug intolerance NOS and Thyroid disorder NOS. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid therapy, METOPROLOL for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Really weak), DIZZINESS (Really dizzy), INFLUENZA LIKE ILLNESS (Feel like with the flu, but no muscle aches), MALAISE (Not well) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ASTHENIA (Really weak), DIZZINESS (Really dizzy), INFLUENZA LIKE ILLNESS (Feel like with the flu, but no muscle aches), MALAISE (Not well) and PYREXIA (Fever) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: high (High) heart rate went up.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant products used included A-fib medication NOS. Patient  have been using the app. The patient reported that last March they had similar symptoms and possibly had COVID-19 since they didn't taste sour cucumbers.
almost lost an eye; This case was reported by a consumer via interactive digital media and described the occurrence of vision decreased in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vision decreased. On an unknown date, the outcome of the vision decreased was unknown.   It was unknown if the reporter considered the vision decreased to be related to Shingles vaccine.  Additional details were provided as follows: The patient was reporter's mother. The age at vaccination was not reported. The patient almost lost her eye with vaccine. The follow-up would not possible, as no contact details were available. This case had been linked with US2021AMR020524, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR020524:same reporter
I contracted COVID-19 4/30/2022 with symptoms of fever, congestion, sore throat, myalgia, headache, cough, and my symptoms are beginning to resolve. I began taking Paxlovid 5/1/2022.
Erythematous swelling (R) arm noted within 24 hours of DTaP. No fever; only minimal pain. 9cmx6 1/2cm erythematous non-tender swelling deltoid region. No LNE